Paper40178377
Granulosa cell death is a significant contributor to DNA-damaging chemotherapy-induced ovarian insufficiency†.
Kawano M and 3 others. Biol Reprod, 2025. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Granulosa cell death is a significant contributor to DNA-damaging chemotherapy-induced ovarian insufficiency†. Papers, record 40178377. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40178377
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Granulosa Cells | Major topic |
| Primary Ovarian Insufficiency | Major topic |
| Cyclophosphamide | Major topic |
| Busulfan | Major topic |
| DNA Damage | Major topic |
| Antineoplastic Agents, Alkylating | Major topic |
| Animals | |
| Female | |
| Mice | |
| Apoptosis | |
| Ovarian Follicle | |
| Cell Death |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 HD090050 | NICHD NIH HHS | United States | R01HD090050 | PubMed and NIH | NIH RePORTER |
| Uehara Memorial Foundation and Kanzawa Medical Research Foundation | PubMed | PubMed | |||
| 130426-PF-17-209-01-TBG | American Cancer Society | PubMed | PubMed | ||
| #SAE20151203560 | Fondation ARC pour la Recherche contre le Cancer | PubMed | PubMed | ||
| #130426-PF-17-209-01-TBG | American Cancer Society | PubMed | PubMed | ||
| The Uehara Memorial Foundation and Kanzawa Medical Research Foundation | PubMed | PubMed | |||
| 1R01HD090050-0 | NIH HHS | United States | R01HD090050 | PubMed and NIH | NIH RePORTER |
| SAE20151203560 | Fondation ARC pour la Recherche contre le Cancer | PubMed | PubMed |
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16055554 | Essential role of BAX,BAK in B cell homeostasis and prevention of autoimmune disease. | Proc Natl Acad Sci U S A | 2005 | https://conductscience.org/library/papers/16055554 | PubMed |
| 2 | 30530902 | Inhibitors of apoptosis protect the ovarian reserve from cyclophosphamide. | J Endocrinol | 2019 | https://conductscience.org/library/papers/30530902 | PubMed |
| 3 | 23677591 | Cyclophosphamide triggers follicle activation and "burnout"; AS101 prevents follicle loss and preserves fertility. | Sci Transl Med | 2013 | https://conductscience.org/library/papers/23677591 | PubMed |
| 4 | 26674557 | Fertility preservation in pre-pubertal girls with cancer: the role of ovarian tissue cryopreservation. | Fertil Steril | 2016 | https://conductscience.org/library/papers/26674557 | PubMed |
| 5 | 36084276 | Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: An Open-Label, Multicenter, Phase III Trial. | J Clin Oncol | 2023 | https://conductscience.org/library/papers/36084276 | PubMed |
| 6 | 36888938 | Cancer Treatment-Related Ovarian Dysfunction in Women of Childbearing Potential: Management and Fertility Preservation Options. | J Clin Oncol | 2023 | https://conductscience.org/library/papers/36888938 | PubMed |
| 7 | 33619021 | The Adolescent and Young Adult (AYA) Horizon Study: An AYA Cancer Survivorship Cohort. | Cancer Epidemiol Biomarkers Prev | 2021 | https://conductscience.org/library/papers/33619021 | PubMed |
| 8 | 27458300 | Recommendations for Premature Ovarian Insufficiency Surveillance for Female Survivors of Childhood, Adolescent, and Young Adult Cancer: A Report From the International Late Effects of Childhood Cancer Guideline Harmonization Group in Collaboration With the PanCareSurFup Consortium. | J Clin Oncol | 2016 | https://conductscience.org/library/papers/27458300 | PubMed |
| 9 | 37862420 | CHEK2 signaling is the key regulator of oocyte survival after chemotherapy. | Sci Adv | 2023 | https://conductscience.org/library/papers/37862420 | PubMed |
| 10 | 29795269 | Loss of PUMA protects the ovarian reserve during DNA-damaging chemotherapy and preserves fertility. | Cell Death Dis | 2018 | https://conductscience.org/library/papers/29795269 | PubMed |
| 11 | 31600388 | Ovarian damage from chemotherapy and current approaches to its protection. | Hum Reprod Update | 2019 | https://conductscience.org/library/papers/31600388 | PubMed |
| 13 | 36857094 | Beyond apoptosis: evidence of other regulated cell death pathways in the ovary throughout development and life. | Hum Reprod Update | 2023 | https://conductscience.org/library/papers/36857094 | PubMed |
| 14 | 22137491 | Impact of cancer therapies on ovarian reserve. | Fertil Steril | 2012 | https://conductscience.org/library/papers/22137491 | PubMed |
| 15 | 37797647 | Measuring ovarian toxicity in clinical trials: an American Society of Clinical Oncology research statement. | Lancet Oncol | 2023 | https://conductscience.org/library/papers/37797647 | PubMed |
| 16 | 20023653 | A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. | Nat Neurosci | 2010 | https://conductscience.org/library/papers/20023653 | PubMed |
| 17 | 31717833 | The Impact of Chemotherapy on the Ovaries: Molecular Aspects and the Prevention of Ovarian Damage. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31717833 | PubMed |
| 18 | 37068157 | The future of fertility preservation for women treated with chemotherapy. | Reprod Fertil | 2023 | https://conductscience.org/library/papers/37068157 | PubMed |
| 19 | 21994953 | Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure. | J Clin Endocrinol Metab | 2011 | https://conductscience.org/library/papers/21994953 | PubMed |
| 20 | 17135639 | Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer. | J Clin Oncol | 2006 | https://conductscience.org/library/papers/17135639 | PubMed |
| 21 | 20715176 | A mouse tool for conditional mutagenesis in ovarian granulosa cells. | Genesis | 2010 | https://conductscience.org/library/papers/20715176 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42935693 | Evaluation of inflammatory status and macrophage polarization in premature ovarian insufficiency mice induced by chemotherapy. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42935693 | PubMed |
| 42852174 | Potential Ameliorative Effect of Zosima absinthifolia on Diminished Ovarian Reserve in Rats. | Iran J Pharm Res | 2026 | https://conductscience.org/library/papers/42852174 | PubMed |
| 42851348 | Integrated network toxicology and multi-omics profiling reveal cell cycle, DNA damage repair, and metabolic alterations in cyclophosphamide-induced premature ovarian insufficiency. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42851348 | PubMed |
| 42757484 | Therapeutic effects of exosome‑based hyperin delivery in a cyclophosphamide‑induced mouse model of diminished ovarian reserve. | Mol Med Rep | 2026 | https://conductscience.org/library/papers/42757484 | PubMed |
| 42477697 | Cyclophosphamide-induced animal models of ovarian dysfunction: from molecular mechanisms and modeling strategies to validation criteria. | J Ovarian Res | 2026 | https://conductscience.org/library/papers/42477697 | PubMed |
| 42351968 | Urolithin A-Enhanced Multi-Bioactive Formulation Mitigates Cyclophosphamide-Induced Premature Ovarian Failure Through Suppression of Oxidative-Inflammatory Stress and Preservation of Follicle Fate. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42351968 | PubMed |
| 41989521 | Relationship between different modes of death and premature ovarian insufficiency: a literature review. | Apoptosis | 2026 | https://conductscience.org/library/papers/41989521 | PubMed |
| 41898522 | A Defined Patho-Mechanism for Acute Radiation Syndrome Death and a Three-Drug Regimen to Prevent It. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41898522 | PubMed |
| 41652498 | ANGPTL4 induces granulosa cells proliferation dysfunction in PCOS by regulating the immune microenvironment and WNT signaling pathway. | J Ovarian Res | 2026 | https://conductscience.org/library/papers/41652498 | PubMed |
| 41160728 | Establishment of an optimized chemotherapy-induced mouse model for premature ovarian failure: protocol and findings. | Aging (Albany NY) | 2025 | https://conductscience.org/library/papers/41160728 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40178377
GET https://conductscience.org/api/papers/v1/40178377/references?page=2